Difference between revisions of "Inhalational Alzheimer's"
Jump to navigation
Jump to search
m (Typo) |
|||
| Line 2: | Line 2: | ||
[http://www.ncbi.nlm.nih.gov/pubmed/26343025 Metabolic profiling distinguishes three subtypes of Alzheimer's disease] | [http://www.ncbi.nlm.nih.gov/pubmed/26343025 Metabolic profiling distinguishes three subtypes of Alzheimer's disease] | ||
[http://www.aging-us.com/article/9r5jsre8k4jq7utxj/text Reversal of cognitive decline in Alzheimer's disease] | |||
[http://www.impactaging.com/papers/v8/n2/full/100896.html Inhalational Alzheimer's disease: an unrecognized - and treatable - epidemic] | [http://www.impactaging.com/papers/v8/n2/full/100896.html Inhalational Alzheimer's disease: an unrecognized - and treatable - epidemic] | ||
Revision as of 16:48, 23 September 2016
The newest intervention in the Bredesen Protocol is against Inhalational Alzheimer's:
Metabolic profiling distinguishes three subtypes of Alzheimer's disease
Reversal of cognitive decline in Alzheimer's disease
Inhalational Alzheimer's disease: an unrecognized - and treatable - epidemic
The next page is Lab testing information.